# There may be a differential mechanistic impact on colorectal cancer of lactose-containing foods between lactase persistent and lactase non-persistent populations

**Authors:** Andrew Szilagyi, Polymnia Galiatsatos, Noah Margolese

PMC · DOI: 10.3389/fnut.2026.1671166 · Frontiers in Nutrition · 2026-02-11

## TL;DR

This paper suggests that the impact of dairy foods on colorectal cancer may differ between people who can and cannot digest lactose due to changes in gut bacteria.

## Contribution

The paper introduces the idea that microbiome changes in lactase non-persistent individuals may offer additional anti-cancer benefits from dairy.

## Key findings

- Calcium in dairy has multiple anti-cancer mechanisms, but other nutrients like CLA and lactoferrin may also play a role.
- Lactase non-persistent individuals may develop a gut microbiome rich in Bifidobacteria, which could reduce cancer risk.
- Combining data from lactase persistent and non-persistent populations may lead to inaccurate conclusions about dairy's cancer effects.

## Abstract

It is generally suggested that milk and milk products reduce the risk of colorectal cancer (CRC). While there is some controversy over specific sites affected throughout the colon and the benefits of specific dairy foods (DFs), there is a general consensus that calcium intake is the main mechanism of the cancer-reducing effects. This opinion may be sidelined by several other mechanisms. There is also a potentially important compensatory mechanism in populations with adult genetic lactase deficiency. The microbiome changes occur through a process of adaptation to continued lactose consumption. The bacterial blooms consist largely of Bifidobacterial species. These bacteria may exert anti-neoplastic effects and also increase the capacity of persons with adapted lactase insufficiency to consume dairy products. Bacterial metabolism thus provides a second pathway for lactose digestion. Since the use of Mendelian randomization (MR) accuracy disallow two different pathways for the genetic variable, this process constitutes a horizontal pleiotropy. This narrative review using articles from PubMed and Google Scholar will discuss different nutrients and mechanisms in milk and milk products that are involved in anti-neoplastic effects. The impact of adult lactase deficiency and continued dairy consumption on the microbiome, and its contribution to colorectal cancer reduction, is highlighted. The conclusions from this review are that calcium has multifaceted mechanisms of anti-carcinogenesis, but other nutrients, such as conjugated linoleic acid (CLA), lactoferrin, and folate in the dairy matrix, could also contribute. In lactase non-persistent (LNP) populations adapted to dairy foods, a bifidogenic bloom in the microbiome may add additional anti-neoplastic effects and /or increase dairy food consumption. We argue that predictions of colon cancer effects from dairy foods may be inaccurate, and that evaluating both populations together may confound outcomes.

## Linked entities

- **Chemicals:** lactoferrin (PubChem CID 126456119), folate (PubChem CID 135405876)
- **Diseases:** colorectal cancer (MONDO:0005575)

## Full-text entities

- **Genes:** IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, IL22 (interleukin 22) [NCBI Gene 50616] {aka IL-21, IL-22, IL-D110, IL-TIF, ILTIF, TIFIL-23}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, APC (APC regulator of Wnt signaling pathway) [NCBI Gene 324] {aka BTPS2, DESMD, DP2, DP2.5, DP3, GS}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, IL17C (interleukin 17C) [NCBI Gene 27189] {aka CX2, IL-17C}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, CASR (calcium sensing receptor) [NCBI Gene 846] {aka CAR, EIG8, FHH, FIH, GPRC2A, HHC}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, IL12B (interleukin 12B) [NCBI Gene 3593] {aka CLMF, CLMF2, IL-12B, IMD28, IMD29, NKSF}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, ERBB2 (erb-b2 receptor tyrosine kinase 2) [NCBI Gene 2064] {aka CD340, HER-2, HER-2/neu, HER2, MLN 19, MLN-19}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, HDAC8 (histone deacetylase 8) [NCBI Gene 55869] {aka CDA07, CDLS5, HD8, HDACL1, KDAC8, MRXS6}, TGFA (transforming growth factor alpha) [NCBI Gene 7039] {aka TFGA}, PPARA (peroxisome proliferator activated receptor alpha) [NCBI Gene 5465] {aka NR1C1, PPAR, PPAR-alpha, PPARalpha, hPPAR}, LCT (lactase) [NCBI Gene 3938] {aka LAC, LPH, LPH1}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, CLDN2 (claudin 2) [NCBI Gene 9075] {aka OAZON, claudin-2}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, WNT5A (Wnt family member 5A) [NCBI Gene 7474] {aka hWNT5A}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, TNK2 (tyrosine kinase non receptor 2) [NCBI Gene 10188] {aka ACK, ACK-1, ACK1, p21cdc42Hs}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, NUSAP1 (nucleolar and spindle associated protein 1) [NCBI Gene 51203] {aka ANKT, BM037, LNP, NUSAP, PRO0310p1, Q0310}
- **Diseases:** dysplasia (MESH:D015792), glioma (MESH:D005910), Dietary Inflammatory (MESH:D007249), gastrointestinal symptoms (MESH:D012817), rectal cancer (MESH:D012004), intestinal neoplasm (MESH:D007414), diabetes (MESH:D003920), cancer (MESH:D009369), carcinogenesis (MESH:D063646), non-communicable diseases (MESH:D000073296), colorectal adenoma (MESH:D000236), obesity (MESH:D009765), colon adenocarcinoma (MESH:D003110), CRC (MESH:D015179), DFs (MESH:D007787), carcinogenic (MESH:D011230), Adenomatous Polyposis Coli 'Floxed (MESH:D011125), cytotoxic (MESH:D064420), colitis (MESH:D003092), lactase deficiency (MESH:C562600), polyp (MESH:D011127), inflammatory bowel diseases (MESH:D015212), pits (MESH:C536528), inflammatory intestinal diseases (MESH:D007410)
- **Chemicals:** zinc (MESH:D015032), AOM (MESH:D001397), phosphate (MESH:D010710), deoxycholic acid (MESH:D003840), VITamin D (MESH:D014807), lactate (MESH:D019344), lactose (MESH:D007785), iron (MESH:D007501), disaccharide (MESH:D004187), luminal (MESH:D010634), CLA (MESH:D044243), calcium phosphate (MESH:C020243), polyunsaturated fatty acid (MESH:D005231), oligosaccharides (MESH:D009844), BA (MESH:D001647), calcium salts (-), fatty acids (MESH:D005227), Butyrate (MESH:D002087), LP (MESH:D008070), lipids (MESH:D008055), polyamines (MESH:D011073), SCFAs (MESH:D005232), Folic acid (MESH:D005492), Ca (MESH:D002118), glucose (MESH:D005947), hydrogen (MESH:D006859), acetate (MESH:D000085)
- **Species:** Salmonella (genus) [taxon 590], Bifidobacterium longum (species) [taxon 216816], Lactobacillus (genus) [taxon 1578], Mus musculus (house mouse, species) [taxon 10090], Lactococcus lactis subsp. lactis (subspecies) [taxon 1360], Bifidobacterium adolescentis (species) [taxon 1680], Fusobacterium animalis (species) [taxon 76859], Lactococcus lactis (species) [taxon 1358], Bifidobacterium angulatum (species) [taxon 1683], Bifidobacterium longum subsp. infantis (subspecies) [taxon 1682], Homo sapiens (human, species) [taxon 9606], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Alistipes (genus) [taxon 239759], Bos taurus (bovine, species) [taxon 9913], Fusobacterium nucleatum (species) [taxon 851], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Bifidobacterium bifidum (species) [taxon 1681], Anaerostipes (genus) [taxon 207244]
- **Mutations:** 13910 C/T, Rs4988235, A986S
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12932183/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12932183/full.md

## References

136 references — full list in the complete paper: https://tomesphere.com/paper/PMC12932183/full.md

---
Source: https://tomesphere.com/paper/PMC12932183